Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bojana Djokovic"'
Autor:
Vladislav Volarevic, Bojana Djokovic, Marina Gazdic Jankovic, C. Randall Harrell, Crissy Fellabaum, Valentin Djonov, Nebojsa Arsenijevic
Publikováno v:
Journal of Biomedical Science, Vol 26, Iss 1, Pp 1-14 (2019)
Abstract Background Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the severe side effects, including nephrotoxicity and acute kidney injury (AKI) wh
Externí odkaz:
https://doaj.org/article/83d90f586cbe4b7baaa7241129d84796
Autor:
Valentin Djonov, Nemanja Jovicic, C. Randall Harrell, Nebojsa Arsenijevic, Bojana Djokovic, Marina Gazdic Jankovic, Crissy Fellabaum, Bojana Simovic Markovic, Vladislav Volarevic, Miodrag L. Lukic
Publikováno v:
Volarevic, Vladislav; Markovic, Bojana Simovic; Jankovic, Marina Gazdic; Djokovic, Bojana; Jovicic, Nemanja; Harrell, C Randall; Fellabaum, Crissy; Djonov, Valentin Georgiev; Arsenijevic, Nebojsa; Lukic, Miodrag L (2019). Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs. Theranostics, 9(20), pp. 5976-6001. Ivyspring International 10.7150/thno.33959
Theranostics
Theranostics
Strategies targeting cross-talk between immunosuppressive renal dendritic cells (DCs) and T regulatory cells (Tregs) may be effective in treating cisplatin (CDDP)-induced acute kidney injury (AKI). Galectin 3 (Gal-3), expressed on renal DCs, is known
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75592c32ba3cbaa7726ffd0fbb5a77a2
https://doi.org/10.7150/thno.33959
https://doi.org/10.7150/thno.33959
Autor:
Vladislav Volarevic, Bojana Djokovic, Crissy Fellabaum, C. Randall Harrell, Marina Gazdic Jankovic, Nebojsa Arsenijevic
Publikováno v:
Serbian Journal of Experimental and Clinical Research.
Cisplatin (cis-diamminedichloroplatinum II) is a widely used chemotherapeutic agent. However, efficacy and clinical utility of this drug is significantly limited by severe side effects such as nephrotoxicity which develops due to renal accumulation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::749ac3cd820e383877ddd9d80c8d22f3
https://doi.org/10.2478/sjecr-2019-0012
https://doi.org/10.2478/sjecr-2019-0012
Autor:
Vladislav Volarevic, Marina Gazdic Jankovic, Nebojsa Arsenijevic, Crissy Fellabaum, Bojana Djokovic, C. Randall Harrell, Valentin Djonov
Publikováno v:
Journal of Biomedical Science
Journal of Biomedical Science, Vol 26, Iss 1, Pp 1-14 (2019)
Volarevic, Vladislav; Djokovic, Bojana; Jankovic, Marina Gazdic; Harrell, C Randall; Fellabaum, Crissy; Djonov, Valentin; Arsenijevic, Nebojsa (2019). Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of biomedical science, 26(1), p. 25. BioMed Central 10.1186/s12929-019-0518-9
Journal of Biomedical Science, Vol 26, Iss 1, Pp 1-14 (2019)
Volarevic, Vladislav; Djokovic, Bojana; Jankovic, Marina Gazdic; Harrell, C Randall; Fellabaum, Crissy; Djonov, Valentin; Arsenijevic, Nebojsa (2019). Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. Journal of biomedical science, 26(1), p. 25. BioMed Central 10.1186/s12929-019-0518-9
Background Cisplatin (cis-diamminedichloroplatinum II, CDDP) is one of the most effective chemotherapeutic agents. However, its clinical use is limited due to the severe side effects, including nephrotoxicity and acute kidney injury (AKI) which devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f23eda4ce7ae34f2c35760f3c4fca741
https://pubmed.ncbi.nlm.nih.gov/30866950
https://pubmed.ncbi.nlm.nih.gov/30866950